Library
5-IAI
A monoamine triple releaser first synthesised by David Nichols, possesses similar properties to MDMA. Probably neurotoxic in humans, however the extent of this is unclear.
Also known as: NRG-5
Classification
- Chemical: Aminoindane
- Psychoactive: Entactogen
- Psychoactive: Psychedelic
- Psychoactive: Stimulant
- Tag: Empathogen
- Tag: Habit-Forming
- Tag: Research-Chemical
Effects
- Increased Energyalertness
- Decreased Need For Sleep
- Decreased Appetite
- Weight Loss
- Sweating
- Distrubed Sleep Patterns
- Euphoria
- Increased Sociability
- Mood Lift
- Excessive Talking
- Agressiveness
- Moodiness
- Increased Sexuality
- Visual And Audiotory Hallucinations Itchiness
- Open Eye Visuals
- Visual Trails
- Color Enhancement
- Tactile Enhancement
Routes of Administration
Oral
Dosage
- Heavy: ≥300 mg
- Light: 50–100 mg
- Common: 100–200 mg
- Strong: 200–300 mg
- Threshold: 40 mg
Duration
- Onset: 0.33-1 h
- Peak: 1-2.5 h
- Offset: 2-3 h
- After Effects: 1-24 h
- Total Duration: 2-6 h
Insufflated
Dosage
- Heavy: ≥180 mg
- Light: 30–60 mg
- Common: 60–120 mg
- Strong: 120–180 mg
- Threshold: 20 mg
Duration
- Onset: 0.08-0.25 h
- Peak: 0.75-2 h
- Offset: 1-2 h
- After Effects: 1-12 h
- Total Duration: 2-5 h
Rectal
Dosage
- Heavy: ≥220 mg
- Light: 40–80 mg
- Common: 80–150 mg
- Strong: 150–220 mg
- Threshold: 30 mg
Duration
- Onset: 0.08-0.25 h
- Peak: 1-2 h
- Offset: 1.5-3 h
- After Effects: 1-18 h
- Total Duration: 2.5-6 h
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
